RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shedir Pharma Srl Unipersonale Stock

Shedir Pharma Srl Unipersonale Revenue 2024

Shedir Pharma Srl Unipersonale Revenue

64.44 M EUR

Ticker

SHE.MI

ISIN

IT0005379620

In 2024, Shedir Pharma Srl Unipersonale's sales reached 64.44 M EUR, a 8.49% difference from the 59.39 M EUR sales recorded in the previous year.

The Shedir Pharma Srl Unipersonale Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
2026e71.4550,12
2025e68.3852,37
2024e64.4455,57
202359.3960,29
202253.4856,61
202144.7457,71
202043.0559,02
201950.2261,52
201846.8766,31
201739.8326,81

Shedir Pharma Srl Unipersonale Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Shedir Pharma Srl Unipersonale, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Shedir Pharma Srl Unipersonale from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Shedir Pharma Srl Unipersonale’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Shedir Pharma Srl Unipersonale. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Shedir Pharma Srl Unipersonale’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Shedir Pharma Srl Unipersonale’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Shedir Pharma Srl Unipersonale’s growth potential.

Shedir Pharma Srl Unipersonale Revenue, EBIT and net profit per share

DateShedir Pharma Srl Unipersonale RevenueShedir Pharma Srl Unipersonale EBITShedir Pharma Srl Unipersonale Net Income
2026e71.45 M undefined11.81 M undefined8.23 M undefined
2025e68.38 M undefined9.9 M undefined6.93 M undefined
2024e64.44 M undefined9.19 M undefined6.46 M undefined
202359.39 M undefined8.49 M undefined5.7 M undefined
202253.48 M undefined8.16 M undefined5.93 M undefined
202144.74 M undefined6.02 M undefined3.93 M undefined
202043.05 M undefined6.35 M undefined3.93 M undefined
201950.22 M undefined6.05 M undefined2.84 M undefined
201846.87 M undefined9.51 M undefined6.51 M undefined
201739.83 M undefined5.42 M undefined3.47 M undefined

Shedir Pharma Srl Unipersonale stock margins

The Shedir Pharma Srl Unipersonale margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shedir Pharma Srl Unipersonale. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shedir Pharma Srl Unipersonale.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Shedir Pharma Srl Unipersonale's sales revenue. A higher gross margin percentage indicates that the Shedir Pharma Srl Unipersonale retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Shedir Pharma Srl Unipersonale's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Shedir Pharma Srl Unipersonale's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Shedir Pharma Srl Unipersonale's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Shedir Pharma Srl Unipersonale. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Shedir Pharma Srl Unipersonale's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Shedir Pharma Srl Unipersonale Margin History

Shedir Pharma Srl Unipersonale Gross marginShedir Pharma Srl Unipersonale Profit marginShedir Pharma Srl Unipersonale EBIT marginShedir Pharma Srl Unipersonale Profit margin
2026e60.29 %16.53 %11.53 %
2025e60.29 %14.48 %10.13 %
2024e60.29 %14.26 %10.03 %
202360.29 %14.3 %9.6 %
202256.61 %15.26 %11.08 %
202157.71 %13.45 %8.77 %
202059.02 %14.75 %9.12 %
201961.52 %12.05 %5.65 %
201866.31 %20.29 %13.89 %
201726.81 %13.61 %8.72 %

Shedir Pharma Srl Unipersonale Aktienanalyse

What does Shedir Pharma Srl Unipersonale do?

Shedir Pharma Srl Unipersonale ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Shedir Pharma Srl Unipersonale's Sales Figures

The sales figures of Shedir Pharma Srl Unipersonale originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Shedir Pharma Srl Unipersonale’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Shedir Pharma Srl Unipersonale's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Shedir Pharma Srl Unipersonale’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Shedir Pharma Srl Unipersonale stock

How much revenue did Shedir Pharma Srl Unipersonale generate this year?

Shedir Pharma Srl Unipersonale has achieved a revenue of 64.44 M EUR this year.

How much was the turnover of the company Shedir Pharma Srl Unipersonale compared to the previous year?

The revenue of Shedir Pharma Srl Unipersonale has increased by 8.49% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Shedir Pharma Srl Unipersonale?

The revenue of Shedir Pharma Srl Unipersonale is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Shedir Pharma Srl Unipersonale measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Shedir Pharma Srl Unipersonale so important for investors?

The revenue of Shedir Pharma Srl Unipersonale is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Shedir Pharma Srl Unipersonale pay?

Over the past 12 months, Shedir Pharma Srl Unipersonale paid a dividend of 0.34 EUR . This corresponds to a dividend yield of about 9.08 %. For the coming 12 months, Shedir Pharma Srl Unipersonale is expected to pay a dividend of 0.38 EUR.

What is the dividend yield of Shedir Pharma Srl Unipersonale?

The current dividend yield of Shedir Pharma Srl Unipersonale is 9.08 %.

When does Shedir Pharma Srl Unipersonale pay dividends?

Shedir Pharma Srl Unipersonale pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Shedir Pharma Srl Unipersonale?

Shedir Pharma Srl Unipersonale paid dividends every year for the past 6 years.

What is the dividend of Shedir Pharma Srl Unipersonale?

For the upcoming 12 months, dividends amounting to 0.38 EUR are expected. This corresponds to a dividend yield of 10.1 %.

In which sector is Shedir Pharma Srl Unipersonale located?

Shedir Pharma Srl Unipersonale is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shedir Pharma Srl Unipersonale kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shedir Pharma Srl Unipersonale from 5/10/2023 amounting to 0.175 EUR, you needed to have the stock in your portfolio before the ex-date on 5/8/2023.

When did Shedir Pharma Srl Unipersonale pay the last dividend?

The last dividend was paid out on 5/10/2023.

What was the dividend of Shedir Pharma Srl Unipersonale in the year 2023?

In the year 2023, Shedir Pharma Srl Unipersonale distributed 0.13 EUR as dividends.

In which currency does Shedir Pharma Srl Unipersonale pay out the dividend?

The dividends of Shedir Pharma Srl Unipersonale are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shedir Pharma Srl Unipersonale

Our stock analysis for Shedir Pharma Srl Unipersonale Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shedir Pharma Srl Unipersonale Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.